Search research articles
Contact Us
Filters
Showing results (191-200 of 550) with videos related to
Page
of 55
Sort By:
Transplantation
|
October 1, 1972
Some effects of a partially purified lymphocyte-inhibiting factor from calf thymus
N Kiger, I Florentin, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1996
Lymphangiographic study of pelvic adenopathy regression in a phase II trial of methyl-hydroxy-ellipticine in HIV1-AIDS complex
G Mathé, M Hallard, P Pontiggia
Cellular Immunology
|
April 1, 1976
The lymphocyte inhibiting factor extracted from the thymus (LIFT): inhibition of the DNA synthesis in vitro
I Florentin, N Kiger, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1988
Human thymic epithelium in culture: an experimental model for the study of thymic microenvironment
F Osculati, G Balercia, G Mathé
European Journal of Cancer
|
February 1, 1970
The time factor in cancer chemotherapy
G Mathé, M Schneider, L Schwarzenberg
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
New cancer chemotherapy drugs in Europe
G Mathé, L M van Putten
La Nouvelle Presse Medicale
|
June 24, 1972
[The anticancer drugs for use by the physician]
G Mathé, L Schwarzenberg, P Pouillart
La Revue Du Praticien
|
October 11, 1974
[Histopathology and histogenesis of Hodgkin's disease]
D Belpomme, H Rappaport, G Mathé
Bulletin Du Cancer
|
July 1, 1974
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia]
J Malpas, G Mathé, M Hayat
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1985
[Bacteriological study of hygienic conditions in the Department of Blood Diseases and Tumors of the Paul Brousse Hospital at Villejuif. I. The atmospheric flora]
L Jacques, D Mathieu, G Mathé
Page
of 55
Search research articles
Search
Showing results (191-200 of 550) with videos related to
Sort By:
Page
of 55
Transplantation
|
October 1, 1972
Some effects of a partially purified lymphocyte-inhibiting factor from calf thymus
N Kiger, I Florentin, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1996
Lymphangiographic study of pelvic adenopathy regression in a phase II trial of methyl-hydroxy-ellipticine in HIV1-AIDS complex
G Mathé, M Hallard, P Pontiggia
Cellular Immunology
|
April 1, 1976
The lymphocyte inhibiting factor extracted from the thymus (LIFT): inhibition of the DNA synthesis in vitro
I Florentin, N Kiger, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1988
Human thymic epithelium in culture: an experimental model for the study of thymic microenvironment
F Osculati, G Balercia, G Mathé
European Journal of Cancer
|
February 1, 1970
The time factor in cancer chemotherapy
G Mathé, M Schneider, L Schwarzenberg
Cancer Chemotherapy and Pharmacology
|
January 1, 1978
New cancer chemotherapy drugs in Europe
G Mathé, L M van Putten
La Nouvelle Presse Medicale
|
June 24, 1972
[The anticancer drugs for use by the physician]
G Mathé, L Schwarzenberg, P Pouillart
La Revue Du Praticien
|
October 11, 1974
[Histopathology and histogenesis of Hodgkin's disease]
D Belpomme, H Rappaport, G Mathé
Bulletin Du Cancer
|
July 1, 1974
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia]
J Malpas, G Mathé, M Hayat
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1985
[Bacteriological study of hygienic conditions in the Department of Blood Diseases and Tumors of the Paul Brousse Hospital at Villejuif. I. The atmospheric flora]
L Jacques, D Mathieu, G Mathé
Page
of 55